Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2023-10-10 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the specifics of a third-party capital increase, including share issuance, pricing, payment dates, and the rationale for the capital change. This falls under the category of share issuance and capital structure changes.
2023-10-10 Korean
소송등의판결ㆍ결정(의결권행사금지가처분 항고)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a court ruling ('소송등의판결ㆍ결정') concerning a legal dispute over voting rights ('의결권행사금지가처분'). It details the case name, court decision, and legal implications. This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2023-09-19 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the issuance of new shares, the purpose of the capital increase, the third-party allocation details, and the revised schedule for payment and listing. This falls under the category of share issuance and capital changes.
2023-08-31 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Helixmith' (헬릭스미스) covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company Helixmith, covering the fiscal year 2022. It contains detailed financial statements, management discussion and analysis, governance information, and audit details. This is a comprehensive annual filing required by regulatory authorities in South Korea, which corresponds to the '10-K' category in the provided schema. FY 2022
2023-07-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the correction of payment dates, listing dates, and financial information of the third-party assignees. This type of filing is a formal regulatory announcement concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-06-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.